SCHEMBL489030

SCHEMBL489030

C=C(C)C(=O)OCC(C)CC(C)CO

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.60
THRB P10828 1/20 0.39
ALDH1A1 P00352 2/20 0.37
TGFBR1 P36897 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31059270 0.92 TSHR (0.69) TSHRTHRBALDH1A1
SCHEMBL607408 0.90 TSHR (0.67) TSHRTHRBALDH1A1TGFBR1
SCHEMBL36570 0.85 TSHR (0.60) TSHRTHRBALDH1A1TGFBR1
SCHEMBL1483913 0.85 TSHR (0.66) TSHRTHRBALDH1A1
SCHEMBL23494026 0.85 TSHR (0.60) TSHRTHRBALDH1A1
SCHEMBL11749779 0.85 TSHR (0.70) TSHRTHRBALDH1A1
SCHEMBL7776916 0.84 TSHR (0.55) TSHRTHRBALDH1A1
SCHEMBL3319370 0.84 TSHR (0.75) TSHRTHRBALDH1A1
SCHEMBL7665484 0.83 TSHR (0.62) TSHRTHRBALDH1A1
SCHEMBL7779126 0.83 TSHR (0.53) TSHRTHRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820844-B2 Charge-modified particles and methods of making the same 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-11-21 US claimed
EP-3768794-A2 CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME 3M Innovative Properties Company (US) 2021-01-27 EP claimed
US-20210009811-A1 MODIFIED ALUMINUM NITRIDE PARTICLES AND METHODS OF MAKING THE SAME 3M INNOVATIVE PROPERTIES COMPANY 2021-01-14 US claimed
US-20210002137-A1 CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME 3M INNOVATIVE PROPERTIES COMPANY 2021-01-07 US claimed
WO-2019180621-A2 CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-09-26 WO claimed
US-9205033-B2 Composite spherical polymer particles and their production process, and cosmetics using the same DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) 2015-12-08 US claimed
EP-3578375-B1 MANUFACTURING METHOD OF LAMINATE PRINTED ARTICLE FUJIFILM CORP (JP) 2024-07-17 EP disclosed
US-20240234226-A9 CURABLE COMPOSITION FOR INKJET AND AIR CAVITY FORMATION, ELECTRONIC COMPONENT, AND METHOD FOR MANUFACTURING ELECTRONIC COMPONENT SEKISUI CHEMICAL CO., LTD. (JP) 2024-07-11 US disclosed
WO-2024143370-A1 COMPOSITE PARTICLE AND LIGHT CONTROL LAMINATED BODY 積水化学工業株式会社 2024-07-04 WO disclosed
WO-2024143369-A1 COMPOSITE PARTICLE AND LIGHT CONTROL LAMINATE 積水化学工業株式会社 2024-07-04 WO disclosed
US-20240166902-A1 ACTIVE ENERGY RAY-CURABLE INKJET INK, AND PRINTED MATTER TOYO INK SC HOLDINGS CO., LTD. (JP) 2024-05-23 US disclosed
US-20240136239-A1 CURABLE COMPOSITION FOR INKJET AND AIR CAVITY FORMATION, ELECTRONIC COMPONENT, AND METHOD FOR MANUFACTURING ELECTRONIC COMPONENT SEKISUI CHEMICAL CO., LTD. (JP) 2024-04-25 US disclosed
WO-2024080336-A1 CURABLE COMPOSITION FOR INKJET USE AND FOR AIR CAVITY FORMATION, AND ELECTRONIC COMPONENT 積水化学工業株式会社 2024-04-18 WO disclosed
EP-1739141-A1 Ink composition, image forming method and printed article Fuji Photo Film Co., Ltd. (JP) 2007-01-03 EP disclosed
US-20060257632-A1 Ink composition FUJI PHOTO FILM CO., LTD. 2006-11-16 US disclosed
EP-1721945-A1 Ink composition Fuji Photo Film Co., Ltd. (JP) 2006-11-15 EP disclosed
WO-2006112547-A1 INK COMPOSITION, IMAGE-FORMING METHOD AND RECORDED MEDIUM FUJIFILM CORPORATION (JP) 2006-10-26 WO disclosed
US-20060194029-A1 Ink composition, inkjet recording method using the same, and printed material FUJI PHOTO FILM CO., LTD. 2006-08-31 US disclosed
EP-0909752-B1 DI(METH)ACRYLATES KYOWA YUKA KK (JP) 2001-09-05 EP disclosed
EP-0909752-A1 DI(METH)ACRYLATES Kyowa Yuka Co., Ltd. (JP) 1999-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210002137-A1 CHARGE-MODIFIED PARTICLES AND METHODS OF MAKING THE SAME PCTP, MBOAT1, CA13 TSHR 1659/4885THRB 3742/4885ALDH1A1 3429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.